# FSH 450IU + LH 225IU

## Pergoveris 450 IU + 225 IU

| TAH Drug Code      | [IPER4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPER4)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Used to stimulate follicular development in women with severe deficiency of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | FSH 150 IU + LH 75 IU daily， adjusted dosage after start treatment 7-14 days， each treatment cycle can be extended up to 5 weeks depending on the clinical condition. 5000-10000 IU of hCG or 250 mcg of r-hCG should be given after 24-48 hours of the last dose of Pergoveris.                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Patients who should not use Pergoveris: - Those with hypersensitivity to the active ingredients or excipients - Patients with hypothalamic or pituitary tumors - Patients with ovarian cysts or ovarian enlargement of unknown cause and not due to polycystic ovary syndrome - Patients with unexplained gynecological bleeding - Patients with ovarian， uterine， or breast cancer - Pregnant women - Breastfeeding women Pergoveris should not be used in patients unlikely to achieve a beneficial response， such as: - Patients with primary ovarian failure - Patients with congenital malformations of reproductive organs preventing pregnancy - Patients with uterine fibroids preventing pregnancy |
| Adverse Effects    | Ovarian hyperstimulation， ascites， hydrothorax， oliguria， hypotension， thromboembolism， hypersensitivity reactions， fever， nausea & vomiting， inj site reactions， unintentional multiple pregnancies.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/fsh-450iu-and-lh-225iu-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

